Clinical Trials
6 trialsNCT01722305 2019-07-22
Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma
Mayo Clinic
Phase 1 Completed
NCT00072514 2017-06-29
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01110135 2017-05-24
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
University of Washington
Phase 2 Completed
NCT00074178 2017-04-21
Protocol-B
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00074191 2017-04-21
Protocol-A
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00003278 2016-07-06
Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
Alliance for Clinical Trials in Oncology
Phase 2 Completed